期刊
JOURNAL OF CROHNS & COLITIS
卷 15, 期 9, 页码 1443-1454出版社
OXFORD UNIV PRESS
DOI: 10.1093/ecco-jcc/jjab048
关键词
Inflammatory bowel disease; prediction; prevention; Crohn's disease; ulcerative colitis; biomarkers; precision medicine
Inflammatory bowel disease is a complex chronic disorder with no known cure, causing substantial burden to patients. New strategies for preventing the global increase of IBD are urgently needed. Data on the preclinical period preceding disease diagnosis may hold the key to disease triggers and early intervention, potentially leading to improved understanding, prediction and prevention of the disease.
Inflammatory bowel disease [IBD] is a complex chronic disorder with no clear aetiology and no known cure. Despite recent advances in overall disease management and improved therapeutics, patients with IBD still experience a substantial burden. Furthermore, as the incidence continues to increase in developing areas of the world, it is expected that the burden of IBD to society will increase and exert tremendous pressure on health care systems worldwide. Therefore, new strategies to prevent the global increase of IBD are urgently required. Data are being progressively acquired on the period preceding disease diagnosis, which support the concept that IBD has a preclinical period that may reveal the triggers of disease and may be amenable to early intervention. Having a better knowledge of this preclinical period will increase the potential not only for improved understanding of disease pathogenesis and improved therapeutics, but also for disease prediction and prevention.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据